Polyoxyl 60 hydrogenated castor oil free nanosomal formulation of immunosuppressant Tacrolimus: pharmacokinetics, safety, and tolerability in rodents and humans.
暂无分享,去创建一个
S. Sheikh | Shoukath M. Ali | I. Ahmad | Ateeq Ahmad | K. Maheshwari | P. Kale | A. Sehgal | M. Ahmad | M. Paithankar | Dipak Saptarishi | R. C. Rane
[1] B. Padhi,et al. Nano-liposomal dry powder inhaler of tacrolimus: Preparation, characterization, and pulmonary pharmacokinetics , 2007, International journal of nanomedicine.
[2] M. Estenne,et al. Tacrolimus Pharmacokinetics and Dose Monitoring After Lung Transplantation for Cystic Fibrosis and Other Conditions , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[3] M. Menéndez,et al. Characterization of liposomal tacrolimus in lung surfactant-like phospholipids and evaluation of its immunosuppressive activity. , 2004, Biochemistry.
[4] T. Imayoshi,et al. Effect of FTY720, a novel immunosuppressant, on adjuvant-induced arthritis in rats , 2000, Inflammation Research.
[5] S. Metcalfe,et al. Potential for improved therapeutic index of FK506 in liposomal formulation demonstrated in a mouse cardiac allograft model. , 1999, Transplantation.
[6] Q. Zhang,et al. A specific method for the measurement of tacrolimus in human whole blood by liquid chromatography/tandem mass spectrometry. , 1997, Therapeutic drug monitoring.
[7] S. Pond,et al. Sensitive, specific quantitative analysis of tacrolimus (FK506) in blood by liquid chromatography-electrospray tandem mass spectrometry. , 1996, Clinical chemistry.
[8] W. Jusko. Analysis of Tacrolimus (FK 506) in Relation to Therapeutic Drug Monitoring , 1995, Therapeutic drug monitoring.
[9] W. Jusko,et al. Physicochemical, Pharmacokinetic and Pharmacodynamic Evaluation of Liposomal Tacrolimus (FK 506) in Rats , 1995, Pharmaceutical Research.
[10] B. Griffith,et al. A prospective randomized trial of FK506 versus cyclosporine after human pulmonary transplantation. , 1994, Transplantation.
[11] G. Kootstra,et al. FK 506: monitoring in plasma or in whole blood? , 1991, Transplantation proceedings.
[12] J J Fung,et al. Pharmacokinetics of FK 506: preclinical and clinical studies. , 1990, Transplantation proceedings.